Drugs / Inactivated COVID-19 vaccine (Vero cells)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT05293548 Comparator | May 2022 → May 2023 | COVID-19 | National Vaccine and Serum Institute, China | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated COVID-19 vaccine (Vero cells) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05293548 ↗ |
| Modality | Vaccine | “Biological/Vaccine: Inactivated COVID-19 vaccine (Vero cells)” NCT05293548 ↗ |
| Route | Intramuscular | “Intramuscular injection of Inactivated COVID-19 vaccine (Vero cells) in the deltoid muscle of the upper arm” NCT05293548 ↗ |